Back to search
Treatment-refractory Schizophrenia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Treatment-refractory Schizophrenia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Treatment-refractory Schizophrenia trials you may qualify forThis is a double blind adjunctive randomized controlled trial for schizophrenia using acetazolamide.
This is a prospective, 12-week, randomized, double-blind, placebo-controlled study, designed to evaluate the efficacy, safety, and tolerability of a dose of eve…
The purpose of this pilot study is to investigate the use of deep brain stimulation (DBS) of the substantia nigra pars reticulata (SNr) in subjects with treatme…
Schizophrenia is one of the most severe and costliest mental disorders in terms of human suffering and societal expenditure. About 15-30% of patients do not res…
This trial aims to assess the clinical effects and tolerability of Magnetic Seizure Therapy (MST) as an alternative to electroconvulsive therapy (ECT) for Treat…
Using a randomized controlled design, the project aims to test if cognitive behavioral therapy interventions specifically targeting sleep disorders can signific…
The effectiveness and efficacy of the combination of pharmacotherapy with the two new recovery-oriented programs, RECOVERYTRSGR for patients with treatment- res…
This pilot study aims to investigate the use of MRI-guided low-intensity focused ultrasound (LIFU) to modulate neuronal activity within the thalamus in human su…